Plasma therapy or convalescent plasma therapy is one of the most popular and constructive methods to boost the immune system. It involves use of blood from a person who has recently recovered from an illness to donate it to someone who is currently suffering from the same disease. This blood is likely to contain antibodies that are essential to fight the illness, especially when the patient’s immune system is not positively responding.
According to Allied Market Research, the global plasma therapy market is projected to reach $698.46 million by 2030, registering a CAGR of 8.5% from 2021 to 2030. The surge in the geriatric population and prevalence of rare diseases, the rise in the number of androgenic alopecia patients, and increase in the number of plasma collection centers drive the growth of the market.
The use of plasma therapy has proven to be effective for back pain and dermatological treatment. As this method of treatment is considered to be much safer, the use of plasma therapy for orthopedic illnesses and skin diseases has increased drastically. The therapy is less painful, causes less thermal damage and bleeding during the process, and improves the recovery period considerably. More importantly, it poses no risk of transurethral resection (TUR) syndrome and other side effects.
Platelet-rich plasma (PRP) therapy gained traction for dealing with skin diseases. The treatment gained popularity as a “vampire facial” as it used plasma from other patients to stimulate skin regeneration. People who are more concerned about injecting foreign chemicals into their bodies prefer to undergo plasma therapy, especially treating hair regeneration and acne scarring. What’s more, PRP therapy can stimulate hair growth cells and help gain thicker hair over time.
Apart from the treatment of skin diseases, plasma therapy to treatment of the orthopedic condition is considered to be one of the rapidly-evolving branches of science. Several clinical results show that PRP is a more promising method to treat soft tissues and bone-related injuries compared to traditional methods. Now, plasma therapy is recommended to treat various conditions such as rotator cuff injury, Achilles tendinopathy, and lateral epicondylitis.
Impact of COVID-19 Pandemic on the Plasma Therapy Market
Plasma from the blood of a patient who recovered from the COVID-19 was used for treatment of another patient suffering from COVID-19. Convalescent plasma can potentially develop as an effective treatment option to battle against the pandemic. Thus, rise in demand for plasma derived immunoglobulins for treatment procedures for COVID-19 patients with autoimmune and inflammatory disorders, which is anticipated to drive growth of the plasma fractionation market for immunoglobulin.
Plasma therapy is used for treatment of many disorders such as hair loss, tendon injuries, acute injuries, post-surgical repair, and osteoarthritis and currently for treatment of COVID–19. Furthermore, several manufacturers are initiating plasma processing to tackle the spread of coronavirus across the world. Therefore, the global plasma therapy market is expected to witness significant growth during the forecast period.
During the Covid-19 outbreak, plasma therapy was used. Until researchers could find a vaccine or proper method of treatment for a novel viral infection, plasma therapy offers the best chance to fight the disease. However, plasma therapy still needs the support of clinical trials for its widespread use, they have proven to be effective in treating chronic illness. Thus, in the future, more companies would invest in clinical trials and make it an ideal method of treatment for fighting novel infections or outbreaks.
“Growth of the plasma therapy market is driven by rise in prevalence of life-threatening diseases, which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN) is anticipated to augment growth of the global plasma therapy market.” 
Onkar Sumant
Manager, Healthcare at Allied Market Research
0 Comments